Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,060) with videos related to
Page
of 106
Sort By:
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
The New England Journal of Medicine
|
July 6, 2017
Declining Risk of Sudden Death in Heart Failure
Li Shen, Pardeep S Jhund, Mark C Petrie, et al.
Journal of the American College of Cardiology
|
October 7, 2017
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
Phillip H Lam, Daniel J Dooley, Prakash Deedwania, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 21, 2025
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair D Henderson, Inder S Anand, et al.
European Journal of Heart Failure
|
August 22, 2024
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment
Mingming Yang, Toru Kondo, Inder S Anand, et al.
Journal of the American Heart Association
|
April 23, 2025
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF Trial
Henri Lu, Brian L Claggett, Masatoshi Minamisawa, et al.
European Journal of Heart Failure
|
February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
European Journal of Heart Failure
|
December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Xiaowen Wang, Orly Vardeny, Brian Claggett, et al.
European Journal of Heart Failure
|
August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Senthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
European Heart Journal
|
August 26, 2022
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation
Toru Kondo, Azmil H Abdul-Rahim, Atefeh Talebi, et al.
Page
of 106
Search research articles
Search
Showing results (1011-1020 of 1,060) with videos related to
Sort By:
Page
of 106
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
The New England Journal of Medicine
|
July 6, 2017
Declining Risk of Sudden Death in Heart Failure
Li Shen, Pardeep S Jhund, Mark C Petrie, et al.
Journal of the American College of Cardiology
|
October 7, 2017
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
Phillip H Lam, Daniel J Dooley, Prakash Deedwania, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 21, 2025
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair D Henderson, Inder S Anand, et al.
European Journal of Heart Failure
|
August 22, 2024
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment
Mingming Yang, Toru Kondo, Inder S Anand, et al.
Journal of the American Heart Association
|
April 23, 2025
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF Trial
Henri Lu, Brian L Claggett, Masatoshi Minamisawa, et al.
European Journal of Heart Failure
|
February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
European Journal of Heart Failure
|
December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Xiaowen Wang, Orly Vardeny, Brian Claggett, et al.
European Journal of Heart Failure
|
August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Senthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
European Heart Journal
|
August 26, 2022
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation
Toru Kondo, Azmil H Abdul-Rahim, Atefeh Talebi, et al.
Page
of 106